Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2026AAPS PharmSciTechOpen Access

Synthesis and Optimization of PEG-PLGA Immunotherapeutic Nanoparticles for the Controlled Release of IFNα

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMagdi AbobakerUniversity of the WitwatersrandMGMershen GovenderUniversity of the WitwatersrandYCYahya E. ChoonaraUniversity of the Witwatersrand

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Abobaker et al. (2026) studied this question.

synapsesocial.com/papers/6abdf87766f37546185171eahttps://doi.org/10.1208/s12249-026-03548-7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Optimization of Cardiovascular Stent against Restenosis: Factorial Design-Based Statistical Analysis of Polymer Coating Conditions2012 · 51 citations
  2. 2ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma2024 · 106 citations
  3. 3Solvent Evaporation Processes for the Production of Controlled Release Biodegradable Microsphere Formulations for Therapeutics and Vaccines1998 · 76 citations
  4. 4Double-edged effects of interferons on the regulation of cancer-immunity cycle2021 · 62 citations
  5. 5Progress and challenges towards targeted delivery of cancer therapeutics2018 · 2,239 citations